Pregnant patients in the United States are now navigating something that did not exist a year ago: two credible immunization schedules that do not match. And for the first time, they have hard numbers on infant hospitalizations to bring into that conversation.
Researchers at the University of Pittsburgh and UPMC reported in JAMA Network Open on June 5 that among infants younger than three months, maternal RSV vaccination was associated with roughly 68 percent effectiveness against hospitalization for RSV-related respiratory illness and about 69 percent effectiveness against more severe lower respiratory tract disease.
